NLRP3 and central nervous system cancer: Blocking NF-κB attenuates IL-1β and NLRP3 overexpression and increases cell growth and invasion, and NLRP3 promotes glioma growth and invasion through IL-1β/ NF-κB P65 signaling (Wang et al. 2019).